RVPH
REVIVA PHARMACEUTICALS HOLDINGS, INC.Company Information
- Company Name
- REVIVA PHARMACEUTICALS HOLDINGS, INC.
- CIK
- CIK0001742927
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- RVPH: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- RVPH
SEC filing data through
Insider Sentiment
- Last purchase
- 2022-11-18
- Last sale
- 2020-12-08
- Shares purchased (TTM)
- 103,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 3,367,852
- Shares outstanding
- 7,022,945
- Ownership
- 47.95%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- 15.09%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents At Carrying Value | 20 | 22 | 14 | 13 | 10 | 5 | 13 | 6 | 6 | 12 | 23 | 5 | ||||||
| Assets Current | 21 | 24 | 15 | 14 | 11 | 6 | 15 | 7 | 7 | - | 24 | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | ||||||
| Prepaid Expense Noncurrent | - | - | - | - | - | - | - | - | 1 | - | - | - | ||||||
| Assets | 21 | 24 | 16 | 14 | 12 | 7 | 16 | 8 | 8 | 13 | 24 | 5 | ||||||
| Short Term Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accounts Payable Current | 2 | 2 | 3 | 5 | 5 | 5 | 6 | 9 | 5 | 6 | 4 | 5 | ||||||
| Liabilities Current | 6 | 6 | 7 | 10 | 12 | 12 | 15 | 18 | 14 | 14 | 17 | 13 | ||||||
| Employee Related Liabilities Current | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | ||||||
Liabilities | ||||||||||||||||||
| Liabilities | 6 | 6 | 7 | 10 | 12 | 12 | 15 | 18 | 14 | 15 | 18 | 14 | ||||||
| Other Accrued Liabilities Current | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | - | ||||||
| Derivative Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Liabilities And Stockholders Equity | 21 | 24 | 16 | 14 | 12 | 7 | 16 | 8 | 8 | 13 | 24 | 5 | ||||||
Stockholders Equity Note | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 15 | 17 | 9 | 5 | -0 | -4 | 1 | -10 | -6 | -1 | 6 | -13 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Additional Paid In Capital | 205 | 205 | 193 | 185 | 176 | 166 | 165 | 148 | 144 | 140 | 140 | 112 | ||||||
| Retained Earnings Accumulated Deficit | -190 | -187 | -184 | -181 | -177 | -171 | -164 | -158 | -150 | -142 | -134 | -121 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 515 | 515 | 315 | 315 | 315 | 315 | 315 | 115 | 115 | 115 | 315 | 115 | ||||||
| Shares Outstanding | 13 | 13 | 6 | 5 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Common Stock Shares Issued | 13 | 13 | 6 | 5 | 3 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialREVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) — SEC Financial Statements & Analysis
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) is a pharmaceutical preparations company, incorporated in DE. REVIVA PHARMACEUTICALS HOLDINGS, INC. trades on OTC as: RVPH. REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, REVIVA PHARMACEUTICALS HOLDINGS, INC. carries a market cap of $8.31M, a P/E ratio of -0.64x, a P/B ratio of 0.55x, an enterprise value of $-11.44M, and an EV/EBITDA multiple of 0.85x. On profitability, it posts a Return on Equity (ROE) of -176.60% and a Return on Assets (ROA) of -79.46%. Per share, it reports EPS of $-0.99, free cash flow per share of $-1.31, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -51.97% year-over-year and EPS growth of -90.83% year-over-year. On the balance sheet, it maintains a current ratio of 3.56x, a quick ratio of 3.50x, working capital of $15.21M, a debt-to-equity ratio of 0.39x, a debt ratio of 0.28, an interest coverage ratio of -756.66x, free cash flow of $-17.30M (TTM), and net debt of $-19.75M. Figures sourced from SEC EDGAR.
- Market Cap
- $8.31M
- P/E TTM
- -0.64x
- EPS TTM
- $-0.99
- P/B TTM
- 0.55x
- ROE TTM
- -176.60%
- ROA TTM
- -79.46%
- Debt To Equity
- 0.39x
- Free Cash Flow TTM
- $-17.30M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is REVIVA PHARMACEUTICALS HOLDINGS, INC. in?
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) operates in the Pharmaceutical Preparations industry.
What exchange does RVPH trade on?
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) trades on the OTC.
Where is REVIVA PHARMACEUTICALS HOLDINGS, INC. incorporated?
REVIVA PHARMACEUTICALS HOLDINGS, INC. is incorporated in DE.
When was REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)'s most recent SEC filing?
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is RVPH's market cap?
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) has a market capitalization of $8.31M as of 2026-06-30.
What is RVPH's EPS (earnings per share)?
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)'s trailing twelve month EPS is $-0.99 as of 2026-06-30.
What is RVPH's ROE (return on equity)?
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)'s trailing twelve month Return on Equity (ROE) is -176.60% as of 2026-06-30.
What is RVPH's ROA (return on assets)?
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)'s trailing twelve month Return on Assets (ROA) is -79.46% as of 2026-06-30.
What is RVPH's EV/EBITDA?
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)'s trailing twelve month EV/EBITDA is 0.85x as of 2026-06-30.